QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study.

Direct comparison with hIAPP‐treated cells confirmed a highly significant recovery ( p < 0.001), with ATP levels increasing by ∼19% and slightly exceeding those observed in the vehicle control condition.

also in 132,142 other papers

Co‐treatment with Antp‐ QBP1 showed a clear trend toward reduced OC intensity, with values clustering around ∼18 000 a.u./ cell, in contrast to the broader distribution observed in hIAPP‐treated cells (∼15 000–30 000 a.u./ cell), although this difference did not reach statistical significance (Figure 6A ; and Table S2 ).

also in 19,460 other papers